MM25: A phase 1b/II study of the efficacy of Venetoclax, Iberdomide and Dexamethasone (IberVenD) for patients in first or second relapse of Multiple Myeloma with t(11;14)
ACTRN 12622001158752 Brief Summary This clinical trial aims to assess the effect…
Read more arrow_forward